出血性熱(Hemorrhagic Fever):世界の治験レビュー(2014年下半期版)

◆英語タイトル:Hemorrhagic Fever Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2449CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年11月30日
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥780,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界における出血性熱(Hemorrhagic Fever) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 出血性熱(Hemorrhagic Fever)
  - 当レポートの概要
・出血性熱(Hemorrhagic Fever):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Hemorrhagic Fever Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Hemorrhagic Fever Global Clinical Trials Review, H2, 2014″ provides data on the Hemorrhagic Fever clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemorrhagic Fever. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemorrhagic Fever. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Hemorrhagic Fever 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Hemorrhagic Fever 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Hemorrhagic Fever Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Sanofi 30
Clinical Trial Overview of Sanofi 30
Sarepta Therapeutics, Inc. 31
Clinical Trial Overview of Sarepta Therapeutics, Inc. 31
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
Liaoning Cheng Da Biotechnology Co., Ltd 33
Clinical Trial Overview of Liaoning Cheng Da Biotechnology Co., Ltd 33
Clinical Trial Overview of Top Institutes / Government 34
U.S. Army Medical Research and Materiel Command 34
Clinical Trial Overview of U.S. Army Medical Research and Materiel Command 34
The National Institute of Allergy and Infectious Diseases 35
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 35
University of Maryland 36
Clinical Trial Overview of University of Maryland 36
Five Key Clinical Profiles 37
Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 59

List of Tables
Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Region, 2014* 6
Hemorrhagic Fever Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hemorrhagic Fever Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 9
Hemorrhagic Fever Therapeutics Clinical Trials, Europe, Top Countries, 2014* 10
Hemorrhagic Fever Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Hemorrhagic Fever Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Hemorrhagic Fever Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 14
Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 17
Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Hemorrhagic Fever Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Hemorrhagic Fever Therapeutics, Global, Withdrawn Clinical Trials, 2014* 24
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Hemorrhagic Fever Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 30
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarepta Therapeutics, Inc., 2014* 31
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 32
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by Liaoning Cheng Da Biotechnology Co., Ltd, 2014* 33
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army Medical Research and Materiel Command, 2014* 34
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 35
Hemorrhagic Fever Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Maryland, 2014* 36

List of Figures
Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Hemorrhagic Fever Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Hemorrhagic Fever Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 9
Hemorrhagic Fever Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 13
Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 14
Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Hemorrhagic Fever Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Hemorrhagic Fever to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 17
Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Hemorrhagic Fever Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Hemorrhagic Fever Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Hemorrhagic Fever Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Hemorrhagic Fever Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Hemorrhagic Fever Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 58

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[出血性熱(Hemorrhagic Fever):世界の治験レビュー(2014年下半期版)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆